Skip to main content
. 2019 Mar 19;8(1):45–58. doi: 10.1089/biores.2018.0028

FIG. 1.

FIG. 1.

Trends in patent applications for total iPSC technologies (a), iPSC preparation technologies (b), differentiation technologies (c), and disease-specific cell technologies (d) by filing year. EP, European; iPSC, induced pluripotent stem cell; JP, Japanese; U.S., United States.